Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Neurology 2019].
Perrenoud M, Pantazou V, Michel P, Hirt L, Ryvlin P, Theaudin M, Rouaud O, Benninger D, Novy J, Rossetti AO, Kuntzer T, Diserens K, Pasquier RD. Perrenoud M, et al. Rev Med Suisse. 2020 Jan 15;16(676-7):68-71. Rev Med Suisse. 2020. PMID: 31961088 French.
Novel Treatment and New Drugs in Epilepsy Treatment.
Eskioglou E, Perrenoud MP, Ryvlin P, Novy J. Eskioglou E, et al. Curr Pharm Des. 2017;23(42):6389-6398. doi: 10.2174/1381612823666171024143541. Curr Pharm Des. 2017. PMID: 29076416 Review.
Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.
Caprioglio C, Ribaldi F, Visser LNC, Minguillon C, Collij LE, Grau-Rivera O, Zeyen P, Molinuevo JL, Gispert JD, Garibotto V, Moro C, Walker Z, Edison P, Demonet JF, Barkhof F, Scheltens P, Alves IL, Gismondi R, Farrar G, Stephens AW, Jessen F, Frisoni GB, Altomare D; AMYPAD consortium. Caprioglio C, et al. JAMA Netw Open. 2023 Jan 3;6(1):e2250921. doi: 10.1001/jamanetworkopen.2022.50921. JAMA Netw Open. 2023. PMID: 36637820 Free PMC article.
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium. Altomare D, et al. JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997. JAMA Neurol. 2023. PMID: 37155177 Free PMC article. Clinical Trial.
Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes.
van Coevorden-Hameete MH, van Beuningen SFB, Perrenoud M, Will LM, Hulsenboom E, Demonet JF, Sabater L, Kros JM, Verschuuren JJGM, Titulaer MJ, de Graaff E, Sillevis Smitt PAE, Hoogenraad CC. van Coevorden-Hameete MH, et al. Among authors: perrenoud m. Ann Clin Transl Neurol. 2017 Jul 28;4(9):680-686. doi: 10.1002/acn3.396. eCollection 2017 Sep. Ann Clin Transl Neurol. 2017. PMID: 28904989 Free PMC article.
Assessing neurophobia: A good move.
Perrenoud M. Perrenoud M. J Neurol Sci. 2021 Feb 15;421:117323. doi: 10.1016/j.jns.2021.117323. Epub 2021 Jan 18. J Neurol Sci. 2021. PMID: 33509599 No abstract available.
24 results